GULLO7 Antibody

Clarification of Terminology

The term "GULLO7" appears in source as part of a plant enzyme family (GULO-like oxidases in Arabidopsis thaliana), unrelated to antibodies. No references to "GULLO7 Antibody" exist in immunological contexts.

Likely Confusion:

• GL7 Antibody: A monoclonal antibody targeting a sialic acid glycan moiety (Neu5Ac) on activated lymphocytes and germinal center B cells.

• GULLO7: A plant enzyme (L-gulono-γ-lactone oxidase homolog) in Arabidopsis.

Research Findings and Applications

3.1. Flow Cytometry
GL7 is critical for analyzing B cell activation and germinal center responses. Example workflow:

1. Stimulate splenocytes with Con A or LPS.

2. Stain cells with GL7-Alexa Fluor 488.

3. Analyze via flow cytometry (Blue Laser, 519 nm emission) .

3.2. Strain-Specific Expression

Source:

3.3. Clinical and Diagnostic Relevance
While GL7 is not directly used in clinical diagnostics, its homologs (e.g., CD22-binding antibodies) are studied in autoimmune neuropathies .

Antibody Characterization Challenges

For antibodies like GL7, rigorous validation is essential:

1. Target Specificity: Confirm binding to Neu5Ac via KO cell lines or competitive inhibition .

2. Cross-Reactivity: Exclude non-specific binding to unrelated antigens .

3. Performance in Assays: Optimize titration for flow cytometry (e.g., 0.5 µg/test) .

Source: